A retrospective study of GLP-1 agonist used in type 2 diabetic patients- an example from a regional hospital in mid-taiwan
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: LIN, Chih Kang (Cheng ching hospital, pharmacy, taichung, China Taiwan)
- Co-author(s): Chih Kang Lin:|Hsing Yu Hsu:
Type 2 diabetes mellitus has become the metabolic disease of most concern globally. Good glycemic control is the primary management strategy to reduce serious complications. There has been an increasing interest in the safety and effectiveness of glucagon-like peptide-1(GLP-1) agonists in combination with insulin in the treatment of people with.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.